Skip to main content
MDWD logo

MediWound Ltd.

MDWDNASDAQHealthcareBiotechnology

$12.55Today:- (-)1Y −34.16%

As of Oct 27, 2026 close

Market cap
$161.69M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$11.84$19.93
Volume (live)
-
Avg. volume (3M)
85.17K

MediWound (MDWD) Income Statement

MediWound reported revenue of $16.96M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 16.1% from $20.22M a year earlier. MediWound posted a net loss of $23.88M, compared with a net loss of $30.22M a year earlier. Gross margin was 19.2% and operating margin -149.1%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $3.09M, down 45.8% from the same quarter a year earlier.

MediWound Income Statement Analysis

Values in millions USD

Scroll to see more
MediWound Ltd. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue16.9620.2218.6926.5023.7621.7631.793.402.50
Cost of Revenue13.7117.5915.1113.3314.9914.2211.852.091.58
Gross Profit3.252.633.5813.178.777.5519.941.310.92
Operating Expenses
Research & Development14.328.887.4710.1810.267.704.974.075.46
Selling, General & Administrative13.9312.9111.3810.659.458.699.067.949.09
Operating Expenses28.5322.0219.0821.5119.9916.3915.455.2714.61
Operating Income-25.28-19.38-15.50-8.35-11.22-8.844.49-3.96-13.69
Other Income/Expense
Interest Income1.862.052.340.460.010.300.430.410.35
Interest Expense0.660.750.43-0.100.17-0.830.210.000.00
Other Income/Expense1.57-10.757.87-11.18-2.30-0.45-2.43-1.71-0.85
Income
Income Before Tax-23.71-30.16-6.53-19.52-13.52-9.282.07-5.67-14.53
Income Tax Expense0.170.060.190.080.030.000.000.000.00
Net Income-23.88-30.22-6.72-19.60-13.55-9.204.96-1.06-22.15
Net Income - Continuous Operations-23.88-30.22-6.72-19.60-13.55-9.204.96-1.06-22.15
Net Income - Discontinued Operations---------
EBITDA-21.47-27.93-4.80-6.39-11.38-7.754.14-4.20-13.14
EBIT-23.33-29.41-6.10-7.66-12.62-8.84---
Depreciation & Amortization1.860.230.241.271.241.091.150.580.57
Earnings Per Share
Basic EPS-2.00-3.00-1.00-4.00-3.00-2.001.00--7.00
Diluted EPS-2.00-3.00-1.00-4.00-3.00-2.001.00--7.00
Basic Shares Outstanding11.389.969.014.993.893.883.883.873.33
Diluted Shares Outstanding11.389.969.014.993.893.883.883.873.33

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About MediWound Financial Statements

What was MediWound's revenue in fiscal 2025?

MediWound reported revenue of $16.96M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 16.1% from $20.22M a year earlier.

Is MediWound profitable?

No. MediWound reported a net loss of $23.88M in fiscal 2025. In fiscal 2024 it lost $30.22M.

What is MediWound's operating margin?

MediWound's operating income was −$25.28M on revenue of $16.96M in fiscal 2025, an operating margin of -149.1%, compared with -95.8% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition